Contingency management is a behavioral therapy that rewards people with tangible incentives, like gift cards or prizes, for staying drug-free or meeting other treatment goals. It’s rooted in a simple principle from behavioral psychology: behaviors that are reinforced tend to be repeated. In addiction treatment, this means providing something of value each time a person submits a clean urine sample, attends a therapy session, or takes medication as prescribed. It is one of the most well-studied treatments for stimulant use disorders, where no effective medication currently exists.
How It Works
The core logic is straightforward. A person in treatment provides regular urine samples, and each time the result comes back negative for the target drug, they receive a reward. The reward isn’t just verbal encouragement. It has real monetary value, even if modest: a $5 gift card, a bus token, a chance to win a larger prize. This tangible reinforcement strengthens the connection between staying abstinent and experiencing something positive.
What makes contingency management especially effective is the escalating schedule. The rewards grow with each consecutive clean sample. If your first negative test earns you one chance at a prize, your second consecutive clean test earns two chances, your third earns three, and so on. This creates stronger motivation over time, because the longer your streak of abstinence, the more you stand to gain. If you slip up, the rewards typically reset to the starting level, which adds a real cost to relapsing.
Two Main Reward Models
Treatment programs generally use one of two formats: voucher-based reinforcement or the prize-based “fishbowl” method.
Voucher-Based Reinforcement
In this model, each negative urine sample earns a voucher with a set dollar value that goes into a clinic-managed account. A first clean sample might be worth $5, a second consecutive one $10, a third $15, and so on. Patients accumulate credit and exchange it for goods or services they choose from an approved list. Over the course of treatment, patients in research studies have earned $1,000 or more in vouchers. This model tends to produce longer stretches of continuous abstinence, but the cost per patient is higher.
The Fishbowl Method
The fishbowl (or prize-based) model introduces an element of chance. Instead of a guaranteed dollar amount, each clean sample earns you draws from a container holding 500 slips of paper. About half the slips say “Good job, try again” with no monetary value. The other half are winners: most are small prizes worth about $1 (a gift card, bus token, or similar item), a smaller number are worth around $20, and a single slip is the jumbo prize worth $100. The number of draws escalates with consecutive clean samples, just like the voucher model.
The fishbowl method produces outcomes statistically similar to the voucher approach in head-to-head comparisons, but at a fraction of the cost. The average patient earns about $200 in prizes through the fishbowl method, compared to roughly $600 in voucher trials. The intermittent chance of winning something big creates excitement and engagement that the predictable voucher schedule doesn’t always match.
What It Treats
Contingency management has been studied most extensively for stimulant use disorders, including cocaine and methamphetamine addiction. About two-thirds of clinical trials have focused on stimulant use specifically. This matters because stimulant addiction has no FDA-approved medication. For someone struggling with meth or cocaine, contingency management is one of the few treatments with solid evidence behind it.
The approach has also been tested for opioid use, polysubstance use, alcohol, and tobacco. In opioid treatment programs, it’s sometimes used not to reinforce abstinence from opioids directly (since patients may be on methadone or buprenorphine) but to reward abstinence from other drugs or to reinforce medication adherence and appointment attendance.
How Well It Works Long-Term
A common and fair question is whether the benefits disappear once the rewards stop. A meta-analysis of 23 randomized trials measured abstinence up to one year after incentive delivery ended. Participants who received contingency management were 22% more likely to be abstinent at follow-up (a median of 24 weeks after rewards stopped) compared to those who received other forms of therapy. That’s a modest but statistically meaningful advantage, and it held across different substance types.
The effect isn’t dramatic, which points to an important reality: contingency management works best as part of a broader treatment plan. During the active incentive period, it produces clear improvements in abstinence rates, treatment attendance, and retention. After incentives end, some of that momentum carries forward, but combining it with counseling, peer support, or medication (when available) strengthens the long-term picture.
Why It Hasn’t Been Widely Adopted
Despite strong evidence, contingency management has been slow to reach most treatment clinics. Several barriers explain the gap between research and practice.
Funding is the most obvious obstacle. Clinics need a budget for prizes or vouchers, urine testing supplies, and staff time to run the program. Many treatment centers already operate on thin margins, and adding even a modest per-patient cost feels unmanageable when there’s no dedicated funding stream. Staff members at clinics have described wanting to implement the approach but lacking any budget line for it.
There are also cultural and philosophical objections. Some clinicians and patients worry that paying people to stay sober sends the wrong message, or that it undermines intrinsic motivation. Healthcare workers have expressed concern that patients might view incentives with suspicion, wondering what the “catch” is. Patients themselves have raised fairness concerns, worried that those receiving rewards would be seen as getting special treatment.
Knowledge gaps play a role too. Many addiction treatment providers have never been trained in contingency management, and it wasn’t part of their clinical education. Without understanding the behavioral science behind it, the idea of giving prizes for clean urine samples can seem simplistic or even inappropriate. The additional workload of tracking samples, managing prize inventories, and documenting outcomes also discourages adoption in already-stretched clinics.
Growing Access Through Medicaid
The funding picture is beginning to shift. As of early 2025, five U.S. states have received federal approval to cover contingency management through Medicaid waivers: California, Washington, Montana, Hawaii, and Delaware. Michigan and Rhode Island have applications pending.
California was the first to launch, beginning implementation in March 2023 through its CalAIM waiver. The program covers contingency management for qualifying Medi-Cal members with any substance use disorder. So far, California remains the only approved state confirmed to have started delivering services under its waiver, but the other approved states are expected to follow.
This is a significant development. Medicaid coverage means the cost of incentives and program administration doesn’t fall entirely on clinics, removing what has historically been the biggest barrier. If these state programs demonstrate positive outcomes, broader adoption could follow. West Virginia’s application was denied, illustrating that approval isn’t guaranteed, but the trend is clearly toward expanding access.
What to Expect in a Program
If you or someone you know enters a contingency management program, the experience is relatively simple from the patient’s perspective. You’ll provide urine samples on a regular schedule, typically two or three times per week. After each clean result, you’ll either receive a voucher or draw slips from the fishbowl, depending on the program’s format. Prizes are usually exchanged for gift cards, everyday items from an on-site selection, or credit with approved vendors. Cash is generally not given directly.
Programs typically run for 12 to 24 weeks, though the duration varies. Throughout this period, you’ll usually participate in other forms of treatment as well, whether that’s individual counseling, group therapy, or medication management. Contingency management isn’t designed to replace these approaches. It’s designed to keep you engaged long enough for them to work.